Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
07/1999
07/08/1999WO1999033829A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them
07/08/1999WO1999033825A1 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositons containing them
07/08/1999WO1999033823A1 Nitric oxide releasing chelating agents and their therapeutic use
07/08/1999WO1999033821A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity
07/08/1999WO1999033810A1 Pyridyloxy(thio)alkanoic acid amide derivatives and agricultural/horticultural bactericides
07/08/1999WO1999033809A1 Method for producing isoureas
07/08/1999WO1999033808A1 Pyridine/picoline production process
07/08/1999WO1999033807A2 Synthesis of pharmaceutically useful pyridine derivatives (intermediates) employing free radical substitution reactions to functionalize the 2-position of the pyridine
07/08/1999WO1999033789A1 SUBSTITUTED β-ALANINES
07/08/1999WO1999033786A1 Anti-inflammatory compounds
07/08/1999WO1999033460A1 Acyl guanidine sodium/proton exchange inhibitors and method
07/08/1999WO1999025686B1 Cyclic amine derivatives and their use as drugs
07/08/1999DE19757563A1 Free-flowing catalyst system for olefin polymerisation
07/08/1999CA2316873A1 Pyridine/picoline production process
07/08/1999CA2316382A1 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
07/08/1999CA2316352A1 Acyl guanidine sodium/proton exchange inhibitors and method
07/08/1999CA2316235A1 Substituted .beta.-alanines
07/07/1999EP0927035A1 Thrombin inhibitors
07/07/1999EP0927033A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases
07/07/1999EP0927030A1 Use of aryl n-substituted carboxamides to kill tumors
07/07/1999EP0591508B1 Electrooptical liquid crystal system
07/07/1999CN1221734A New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them
07/07/1999CN1043992C Process for prepn. of indolizine derivatives
07/07/1999CN1043947C Method of controlling insects
07/06/1999US5919970 Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
07/06/1999US5919940 Tert-leucine-thiazol-2-ylamide
07/06/1999US5919937 Forming enantiomerically enriched mixtures of 4-(2-(3-methoxy-4-hydroxyphenyl)-2-phenyl ethyl)pyridine by forming a salt with isomers of 3-bromocamphor-10-sulfonic acid; chemical intermediate to inhibitor synthesis
07/06/1999US5919934 Bisaminothiol and amino compounds with appended pharmacophores, metal complexes of these compounds;
07/06/1999US5919802 Methods of preventing and/or treating temporal lobe epilepsy
07/06/1999US5919796 Antiischemic agents
07/06/1999US5919795 Atherosclerosis therapy
07/06/1999US5919792 Vitronectin receptor antagonists useful for inhibiting bone resorption, treating and preventing diseases including osteoporosis, restenosis, diabetic retinopathy, and tumor growth
07/06/1999US5919786 N,N-disubstituted amic acid derivatives
07/01/1999WO1999032468A1 Anilide derivative, production and use thereof
07/01/1999WO1999032463A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
07/01/1999WO1999032448A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
07/01/1999WO1999032447A2 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
07/01/1999WO1999032437A1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
07/01/1999WO1999032436A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
07/01/1999WO1999032433A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
07/01/1999WO1999032225A2 Catalytic composition based on chiral ligands with molybdenum, tungsten or chromium and method for asymmetric alkylation of allylic substrates
07/01/1999WO1999032117A1 Novel substituted pyridine compounds useful as modulators of acetylcholine receptors
07/01/1999WO1999018916A3 Utilization of onium aldehydes and onium ketones for dying fibers containing keratin
07/01/1999WO1999011621A3 Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents
07/01/1999DE19756261A1 Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide New pyridylalkane aryl, alkene and alkincarbonsäureamide
07/01/1999DE19756236A1 Neue piperazinylsubstituierte Pyridylalkan-, alken- und -alkincarbonsäureamide New piperazinyl substituted pyridylalkane, alkene and -alkincarbonsäureamide
07/01/1999CA2315941A1 Novel substituted pyridine compounds useful as modulators of acetylcholine receptors
07/01/1999CA2311428A1 Anilide derivative, production and use thereof
07/01/1999CA2309661A1 Catalytic composition based on chiral ligands with molybdenum, tungsten or chromium and method for asymmetric alkylation of allylic substrates
07/01/1999CA2300197A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
06/1999
06/30/1999EP0926216A1 Organic electroluminescent device using a triarylamine derivative
06/30/1999EP0926138A1 Diamide compounds and drugs containing the same
06/30/1999EP0926137A1 Picolin acid derivatives useful in the treatment of IL-1 and TNF mediated diseases
06/30/1999EP0926133A1 Iodide ion releasing compound, and silver halide light-sensitive photographic material containing the same
06/30/1999EP0925289A1 Matrix metalloproteinase inhibitors
06/30/1999EP0925278A1 Cytostatic hydroxamic acid derivatives
06/30/1999EP0925268A1 Compound having alkadienyl group as side chain, and liquid crystal composition using same
06/30/1999CN1221417A Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
06/30/1999CN1221401A Calcilytic compounds
06/30/1999CN1220989A The intermediates for preparation of 2-chloro-5-alkyl aminomethylpyridines
06/29/1999US5917049 Process for the preparation of dicarboxylic acids
06/29/1999US5917048 Substituted aryl or heteroarylamides having retinoid-like biological activity
06/29/1999US5917046 Method for producing 2-naphthamide derivative, and compounds for producing 2-naphthamide derivative
06/29/1999US5916905 2,3-substituted pyridines for the treatment of inflammation
06/29/1999US5916889 1,4-disubstituted piperazines
06/24/1999WO1999031077A1 Arylpiperazines having activity at the serotonin 1a receptor
06/24/1999WO1999031066A1 Pyridones as src family sh2 domain inhibitors
06/24/1999WO1999031065A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia
06/24/1999WO1999031064A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
06/24/1999WO1999031063A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
06/24/1999WO1999031062A1 Novel pyridine compounds
06/24/1999WO1999031061A1 Integrin receptor antagonists
06/24/1999WO1999030699A1 Modulators of cysteine protease
06/24/1999WO1999030562A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation
06/24/1999CA2506802A1 Arylpiperazines having activity at the serotonin 1a receptor
06/24/1999CA2313212A1 Modulators of cysteine protease
06/23/1999EP0924205A1 Arylpiperazines having activity at the serotonin 1a receptor
06/23/1999EP0924197A1 Substituted cyclopropyl phenoxymethyl phenyl carbamates and their use as fungicides
06/23/1999EP0923590A1 Combinatorial synthesis and analysis of organometallic compounds and catalysts
06/23/1999EP0923580A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
06/23/1999EP0923571A2 Trisubstituted pyridine compounds for herbicidal use
06/23/1999EP0923556A1 An asymmetric conjugate addition reaction
06/23/1999EP0923555A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
06/23/1999EP0923547A1 Bidentate metalloprotease inhibitors
06/23/1999EP0923510A1 Nitration system, and method for nitration of aromatic compounds
06/23/1999EP0923508A2 Process for preparing fluorine-containing compounds
06/23/1999EP0923372A1 Pyridinone thrombin inhibitors
06/23/1999EP0923371A1 Pharmaceutical compositions comprising tyrphostins
06/23/1999CN1043760C Pyridinecarboximidamide and its acid addition salt and its drug composition
06/22/1999US5914344 Substituted carboxanilide derivative and plant disease control agent comprising same as active ingredient
06/22/1999US5914343 Treating cancer, restenosis, atherosclerosis, host versus graft rejection
06/22/1999CA1340608C Alkoxy-4(1h)-pyridone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
06/17/1999WO1999029750A1 Method for making a transparent polymer material resistant to protein deposit, material obtained by said method, contact lenses and intraocular implants made of said material
06/17/1999WO1999029700A2 Cyclohexadiene-derivatives as pesticides
06/17/1999WO1999029693A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
06/17/1999WO1999029674A1 Retinoic acid mimetic anilides
06/17/1999WO1999029670A2 Aminocarbonyltetralin and dihydronaphtalene derivates as thrombin inhibitors
06/17/1999WO1999029661A1 Adamantane derivatives
06/17/1999WO1999029660A1 Adamantane derivatives
06/17/1999WO1999029647A1 Apoptosis inducer